Suggestions
Craig Kasper
Founder | CEO | Clinician
Craig Kasper is an experienced professional in the healthcare industry, particularly in the field of hearing and balance. Here's what we know about him:
Professional Background
Craig Kasper is the Founder and Managing Director of NYHD | Institute For Hearing & Balance, a position he has held since 2008.4 This demonstrates his long-standing expertise in audiology and related fields.
Advisory Roles
Craig Kasper serves as an advisor for several companies in the healthcare technology space:
His advisory role at Suno, Inc. is particularly relevant, as Suno is a technology company based in New York City that operates at the intersection of health-tech and fintech. Their mission is to enable over 37 million Americans, likely referring to their focus on healthcare solutions.2
Expertise and Influence
Craig Kasper's LinkedIn profile describes him as a "Founder, clinician, business creator/operator, advisor, consultant & public speaker".5 This multifaceted description suggests he has a broad range of experience and expertise in the healthcare industry, particularly in hearing and balance-related fields.
Connection to Suno, Inc.
As an advisor to Suno, Inc., Craig Kasper is likely part of the company's strong panel of advisors who come from various sectors of the healthcare industry. Suno's focus is on building the future of practice management software, particularly for private practices in healthcare.1 Given Kasper's background in audiology and his experience running a healthcare institute, his insights would be valuable for Suno's mission to help private practices succeed.
Craig Kasper's involvement with Suno aligns with the company's goal of providing the right set of tools to help private practices, which they consider "the heart and soul of the healthcare industry".1
Highlights
Data should be one of the the foundational elements to drive decision-making for clinicians and patients.
Congratulations to the team at Neuromod Devices for the publication of their TENT-A3 study outcomes in the peer-reviewed journal Nature Communications. This controlled pivotal trial further demonstrated the benefit of bimodal neuromodulation for those patients who are significantly impacted by the symptom of tinnitus, leading to the FDA approval of Lenire in March 2023.
https://lnkd.in/gym9dBPR
#tinnitus #Lenire #FDA #research #audiology #hearing
It was a pleasure speaking with Richard Bistrong for his Fast Company article sharing the importance of quality communication and an accessible workplace for those with hearing loss. Important and actionable strategies for anyone, with or without hearing impairment.
https://lnkd.in/evgG_kpr
#hearing #hearingloss #tinnitus #strategy
